Poland, Oct. 5 -- Poland based QIAGEN Polska Sp. z o.o. has secured contract from Instytut Matki i Dziecka for Chemical reagents - Delivery of reagents for preparing DNA and RNA libraries and reagents for next generation sequencing (NGS) for the project: "Improving the knowledge and skills of medical staff in the field of perinatal diagnosis of genetically determined diseases, with a focus on early prenatal diagnosis of Inborn Defects of Metabolism". The value of the contract is worth 115000.43 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....